tiprankstipranks
Prelude Therapeutics (PRLD)
NASDAQ:PRLD
US Market

Prelude Therapeutics (PRLD) Technical Analysis

104 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
4Neutral
3Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Prelude Therapeutics’s (PRLD) Moving Averages Convergence Divergence (MACD) indicator is 0.01, suggesting Prelude Therapeutics is a Sell.
Prelude Therapeutics’s (PRLD) 20-Day exponential moving average is 3.81, while Prelude Therapeutics’s (PRLD) share price is $5.67, making it a Buy.
Prelude Therapeutics’s (PRLD) 50-Day exponential moving average is 3.88, while Prelude Therapeutics’s (PRLD) share price is $5.67, making it a Buy.

Prelude Therapeutics (PRLD) Pivot Points

Jul 17, 2024, 06:26 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.74
3.09
3.53
3.89
4.33
4.68
5.12
Fibonacci
3.09
3.40
3.58
3.89
4.19
4.38
4.68
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Prelude Therapeutics (PRLD) Moving Averages

Jul 17, 2024, 06:26 AM
Period
Simple
Exponential
MA5
3.81Buy
3.99Buy
MA10
3.76Buy
3.85Buy
MA20
3.79Buy
3.81Buy
MA50
3.84Buy
3.88Buy
MA100
4.13Buy
3.91Buy
MA200
3.66Buy
3.70Buy
Prelude Therapeutics’s (PRLD) 10-Day exponential moving average is 3.85, while Prelude Therapeutics’s (PRLD) share price is $5.67, making it a Buy.
Prelude Therapeutics’s (PRLD) 100-Day exponential moving average is 3.91, while Prelude Therapeutics’s (PRLD) share price is $5.67, making it a Buy.
Prelude Therapeutics’s (PRLD) stock price is $5.67 and Prelude Therapeutics’s (PRLD) 50-day simple moving average is 3.84, creating a Buy signal.
Prelude Therapeutics’s (PRLD) stock price is $5.67 and Prelude Therapeutics’s (PRLD) 100-day simple moving average is 4.13, creating a Buy signal.
Prelude Therapeutics’s (PRLD) stock price is $5.67 and Prelude Therapeutics’s (PRLD) 200-day simple moving average is 3.66, creating a Buy signal.

Prelude Therapeutics (PRLD) Technical Indicators

Jul 17, 2024, 06:26 AM
Name
Value
Implied Action
RSI (14)
68.53
Neutral
STOCH (9,6)
68.05
Neutral
STOCHRSI (14)
66.73
Neutral
MACD (12,26)
0.01
Sell
ADX (14)
12.75
Buy
Williams %R
-13.07
Sell
CCI (14)
331.35
Sell
ATR (14)
0.35
-
Ultimate Oscillator
55.17
Neutral
ROC
19.37
Buy
Prelude Therapeutics’s (PRLD) Relative Strength Index (RSI) is 68.53, creating a Neutral signal.
Prelude Therapeutics’s (PRLD) Trend Strength Indicator (ADX) is 12.75, creating a Buy signal.
Prelude Therapeutics’s (PRLD) Commodity Channel Index (CCI) is 331.35, creating a Sell signal.
Prelude Therapeutics’s (PRLD) Price Rate of Change (ROC) is 19.37, creating a Buy signal.

FAQ

Is PRLD a Buy, Hold, or Sell?
Based on PRLD’s technical indicators, PRLD is a Strong Buy.
    What is PRLD’s RSI (14)?
    PRLD’s RSI (14) is 68.53, which suggests PRLD is a Neutral.
      What is PRLD’s MACD?
      PRLD’s MACD is 0.01, which suggests PRLD is a Sell.
        What is PRLD’s 5-day moving average?
        PRLD’s 5-day moving average is 3.81, which suggests PRLD is a Buy.
          What is PRLD’s 20-day moving average?
          PRLD 20-day moving average is 3.79, which suggests PRLD is a Buy.
            What is PRLD’s 50-day moving average?
            PRLD’s 50-day moving average is 3.84, which suggests PRLD is a Buy.
              What is PRLD’s 200-day moving average?
              PRLD’s 200-day moving average is 3.66, which suggests PRLD is a Buy.
                What is PRLD’s Williams % R (14)?
                PRLD’s Williams % R (14) is -13.07, which suggests PRLD is a Sell.
                  What is PRLD’s CCI (14)?
                  PRLD’s CCI (14) is 331.35, which suggests PRLD is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis